ACUTE RESPIRATORY INFECTION CAUSED BY RESPIRATORY SYNCYTIAL VIRUS

Clinical trials for ACUTE RESPIRATORY INFECTION CAUSED BY RESPIRATORY SYNCYTIAL VIRUS explained in plain language.

Never miss a new study

Get alerted when new ACUTE RESPIRATORY INFECTION CAUSED BY RESPIRATORY SYNCYTIAL VIRUS trials appear

Sign up with your email to follow new studies for ACUTE RESPIRATORY INFECTION CAUSED BY RESPIRATORY SYNCYTIAL VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New cell therapy could tame deadly immune storms in COVID, flu, and RSV

Disease control Recruiting now

This study tests a new treatment called PRS CK STORM, made from immune and fat cells, to safely reduce the dangerous inflammation (cytokine storm) that can happen in severe viral lung infections like COVID-19, flu, and RSV. About 50 adults who need oxygen therapy will receive eit…

Matched conditions: ACUTE RESPIRATORY INFECTION CAUSED BY RESPIRATORY SYNCYTIAL VIRUS

Phase: PHASE1, PHASE2 • Sponsor: PEACHES BIOTECH • Aim: Disease control

Last updated Jun 15, 2026 19:04 UTC

ACUTE RESPIRATORY INFECTION CAUSED BY RESPIRATORY SYNCYTIAL VIRUS

Get alerted when new ACUTE RESPIRATORY INFECTION CAUSED BY RESPIRATORY SYNCYTIAL VIRUS trials appear

New cell therapy could tame deadly immune storms in COVID, flu, and RSV